3rd Annual Pre-Filled Syringes and Injectables Summit

Conference Overview

The global prefilled syringes market size is anticipated to reach USD 50.83 billion by 2030, expanding at a CAGR of 11.95% from 2022 to 2030, according to a new report by Grand View Research, Inc. Key factors driving the market expansion include technological advancements in auto-injectors and growing usage of prefilled syringes owing to its reduced prices per dose.

As the demand for parenteral dug delivery increases challenges arise in such areas as volume and viscosity of drug delivery as well as quality concerns, strict regulatory requirements, interaction of prefilled syringes with drugs, manufacturing complexity, combination therapies, and lyophilization. Additionally, aseptic processing of parenterals involves challenges such as protecting the sterility of a product as it moves through each phase of formulation, filtering, filling, and packaging.

The current COVID-19 outbreak is expected to have a substantial impact on the industry. The pandemic has resulted in a significant surge in demand for emergency supplies, medical disposables, medicines, and hospital equipment.

As a result of COVID-19, there has been an increase in the production of COVID-19 vaccines, resulting in increased demand for prefilled syringes.

Furthermore, emergency syringes used to treat some of COVID-19’s most significant side effects such as heart damage have historically been scarce. Despite the heightened demand during the outbreak, manufacturers provide various programs that identifies high-quality, protected supply bases for medications that are or could be added to the national drug scarcity list.

3rd Annual Prefilled Syringes and Injections Summit will provide a comprehensive overview for market participants to overcome common industry hurdles and gain knowledge by fostering industry relationships, providing the opportunity for the development of innovative business solutions.